Book contents
- Anxiety in Older People
- Anxiety in Older People
- Copyright page
- Contents
- Contributors
- Chapter 1 Introduction and Conceptual Overview
- Chapter 2 Epidemiology, Risk and Protective Factors
- Chapter 3 Diagnosis of Anxiety Disorders in Older Adults
- Chapter 4 Subthreshold Anxiety in Later Life
- Chapter 5 Cross-cultural Issues in Late-Life Anxiety
- Chapter 6 Clinical Assessment of Late-Life Anxiety
- Chapter 7 Late-Life Anxiety and Comorbid Depression
- Chapter 8 Anxiety and Cognitive Functioning
- Chapter 9 Anxiety in Parkinson’s Disease
- Chapter 10 Anxiety in Older Adults across Care Settings
- Chapter 11 Psychosocial Treatment of Anxiety in Later Life
- Chapter 12 Pharmacological Treatment of Anxiety in Later Life
- Chapter 13 Animal Models in Anxiety Research
- Chapter 14 Late-Life Anxiety
- Index
- References
Chapter 9 - Anxiety in Parkinson’s Disease
Published online by Cambridge University Press: 08 March 2021
- Anxiety in Older People
- Anxiety in Older People
- Copyright page
- Contents
- Contributors
- Chapter 1 Introduction and Conceptual Overview
- Chapter 2 Epidemiology, Risk and Protective Factors
- Chapter 3 Diagnosis of Anxiety Disorders in Older Adults
- Chapter 4 Subthreshold Anxiety in Later Life
- Chapter 5 Cross-cultural Issues in Late-Life Anxiety
- Chapter 6 Clinical Assessment of Late-Life Anxiety
- Chapter 7 Late-Life Anxiety and Comorbid Depression
- Chapter 8 Anxiety and Cognitive Functioning
- Chapter 9 Anxiety in Parkinson’s Disease
- Chapter 10 Anxiety in Older Adults across Care Settings
- Chapter 11 Psychosocial Treatment of Anxiety in Later Life
- Chapter 12 Pharmacological Treatment of Anxiety in Later Life
- Chapter 13 Animal Models in Anxiety Research
- Chapter 14 Late-Life Anxiety
- Index
- References
Summary
Parkinson’s disease (PD) is a chronic, progressive, and disabling neurological disorder. The incidence of PD increases with age, and therefore the disease is predominantly observed in later life. The prevalence of PD is estimated at 1% in individuals aged 60 years and over, 2–3% in those aged 65 years and over, and 10% in those aged 80 years and over (de Rijk et al., 1997). In clinical practice, PD is classified as a movement disorder and is characterized by motor symptoms such as tremor, rigidity, bradykinesia, postural instability, and gait dysfunction. However, there are a large number of non-motor symptoms observed in PD, including neuropsychiatric complications, sleep disorders, fatigue, sensory symptoms, autonomic dysfunction, and gastrointestinal symptoms (Chaudhuri et al., 2011).
- Type
- Chapter
- Information
- Anxiety in Older PeopleClinical and Research Perspectives, pp. 139 - 156Publisher: Cambridge University PressPrint publication year: 2021